China steps up Alzheimer’s, Parkinson’s drug push, looks to TCM

AI justification

Consensus on proactive public health policy addressing critical neurodegenerative crisis | China's proactive push to develop treatments for Alzheimer's and Parkinson's addresses a critical public health challenge with significant societal impact. The initiative aligns with SDG 3 (Good Health and Well-being) and UDHR Article 25 (right to health), representing a positive ethical action with measurable benefits for an aging population.